Education
About Us
Working with TipRanks
Follow Us
Apyx Medical Corporation (APYX)
NASDAQ:APYX
APYX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.76 - $3.22
Previous CloseN/A
Volume28.06K
Average Volume (3M)97.00K
Market Cap
$113.46M
Enterprise Value$101.62M
Total Cash (Recent Filing)$29.30M
Total Debt (Recent Filing)$4.71M
Price to Earnings (P/E)―
Beta2.23
Next Earnings
Nov 06, 2025EPS Estimate
-0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding37,819,477
10 Day Avg. Volume181,024
30 Day Avg. Volume97,004
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.90
Enterprise Value/Revenue2.18
Enterprise Value/Gross Profit3.54
Enterprise Value/Ebitda-8.85
Forecast
1Y Price Target
$3.00Price Target Upside0.00%
Rating ConsensusModerate Buy
Number of Analyst Covering5
Bulls Say, Bears Say
Bulls Say
Market ExpansionApyx Medical entered into a distribution agreement to sell its products in China, with initial campaigns showing strong doctor and patient response.
Regulatory ApprovalsThe company's new all-in-one body contouring platform, Ayon, secured FDA clearance, which boosts confidence in future sales.
Sales ProjectionsPre-ordering activity for Ayon exceeded internal expectations, leading to a raised full-year sales guidance.
Bears Say
Market UncertaintyThere is uncertainty surrounding the timing of the company's ability to fully reengage with global customers and the overarching cosmetic market headwinds.
OEM Sales DeclineThe OEM business posted $1.0 mln (-16% y/y) in sales.
Revenue PerformanceApyx Medical reported Q2 revenue slightly below consensus, reflecting a challenging market environment.
Apyx Medical News
APYX FAQ
What was Apyx Medical Corporation’s price range in the past 12 months?
Apyx Medical Corporation lowest stock price was $0.76 and its highest was $3.22 in the past 12 months.
What is Apyx Medical Corporation’s market cap?
Apyx Medical Corporation’s market cap is $113.46M.
When is Apyx Medical Corporation’s upcoming earnings report date?
Apyx Medical Corporation’s upcoming earnings report date is Nov 06, 2025 which is in 22 days.
How were Apyx Medical Corporation’s earnings last quarter?
Apyx Medical Corporation released its earnings results on Aug 07, 2025. The company reported -$0.09 earnings per share for the quarter, beating the consensus estimate of -$0.093 by $0.003.
Is Apyx Medical Corporation overvalued?
According to Wall Street analysts Apyx Medical Corporation’s price is currently same.
Does Apyx Medical Corporation pay dividends?
Apyx Medical Corporation does not currently pay dividends.
What is Apyx Medical Corporation’s EPS estimate?
Apyx Medical Corporation’s EPS estimate is -0.1.
How many shares outstanding does Apyx Medical Corporation have?
Apyx Medical Corporation has 37,819,477 shares outstanding.
What happened to Apyx Medical Corporation’s price movement after its last earnings report?
Apyx Medical Corporation reported an EPS of -$0.09 in its last earnings report, beating expectations of -$0.093. Following the earnings report the stock price went up 11.224%.
Which hedge fund is a major shareholder of Apyx Medical Corporation?
Currently, no hedge funds are holding shares in APYX
Apyx Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.00 (0.00% )
$3.00 (0.00% )
Hedge Fund Trend
Decreased
By 70.8K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
154.23%
12-Months-Change
Fundamentals
Return on Equity
-156.90%
Trailing 12-Months
Asset Growth
-11.02%
Trailing 12-Months
Company Description
Apyx Medical Corporation
Apyx Medical Corporation is a medical technology company focused on developing and commercializing innovative products for the surgical and aesthetic markets. The company specializes in advanced energy-based devices, particularly those utilizing its proprietary Renuvion technology, which combines helium plasma and radiofrequency energy for precision in soft tissue and skin procedures. Apyx Medical serves a diverse range of healthcare providers, including plastic surgeons, dermatologists, and other medical professionals, aiming to enhance patient outcomes and improve the overall efficiency of surgical procedures.
APYX Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a strategic shift with positive momentum from the AYON system launch and restructuring benefits, countered by revenue declines in OEM and overall sales. The updated revenue guidance indicates optimism for future growth.View all APYX earnings summariesAPYX Stock 12 Month Forecast
Average Price Target
$3.00
▲(0.00% Upside)
Technical Analysis
Ownership Overview
1.58% Insiders
9.37% Mutual Funds
31.60% Other Institutional Investors
53.82% Public Companies and
Individual Investors